Small Caps
China Nonferrous Gold agrees loan extensions
Tajikistan-focussed mineral exploration and mining company China Nonferrous Gold has extended the repayment period for loans in place with CNMC Trade Company, it announced on Wednesday, totalling $146. 5m (£115. 94m).
Grafenia launches perpetual bond facility, issues £3m
Grafenia announced on Wednesday that it has put in place a facility to issue up to £50m of perpetual bonds, and issued £3m of the bonds to investors, raising about £2. 01m before expenses.
Cambridge Cognition joins Covid healthcare worker investigation
Cambridge Cognition is collaborating with 4YouandMe and the Center for International Emergency Medical Services (CIEMS), it announced on Wednesday, to investigate the use of wearables and mobile phones to measure stress recovery in front line healthcare workers caring for Covid-19 positive patients in the United States.
Allergy Therapeutics revenues grow despite Covid-19 disruption
Biotechnology company Allergy Therapeutics reported a "strong" full-year performance on Wednesday despite challenges stemming from the Covid-19 pandemic.
Mission Marketing adapts 'well' to Covid-19 impacts
Media company Mission Group said on Wednesday that while the Covid-19 pandemic had led to a "material impact" on demand, it had "adapted well" to the reality of the outbreak and its effect on trading.
Kodal secures another $1.5m funding for development projects
Lithium-focussed exploration and development company Kodal Minerals has secured sufficient funding resources to accelerate the next phases of its development projects, and to evaluate new opportunities, via a $1. 5m (£1. 19m) unsecured convertible loan agreement with Riverfort Global Opportunities and YA II.
SEC Newgate launches 'TRUE' AI platform in Italy
Communications and research company SEC Newgate announced the launch of the artificial intelligence (AI)-powered ‘TRUE’ platform on Wednesday, which would run “extensive and new-to-market” semantic and reputation assessments.
MaxCyte revenues grow further despite Covid crisis
Clinical-stage cell-based therapies company MaxCyte updated the market on its trading for the six months ended 30 June on Wednesday, saying first half revenues were expected to increase about 30% year-on-year to $10. 9m (£8. 63m).
Portmeirion reports fall in sales as markets begin to recover
Homewares designer and manufacturer Portmeirion Group reported an 8% slide in sales in its first half on Wednesday, to £32m, with its like-for-like sales excluding the Nambé acquisition down 20%.
Covid restrictions affecting productivity for Anglo Asian Mining
Azerbaijan-focussed gold, silver and copper producer Anglo Asian Mining reported a $3. 2m (£2. 53m) increase in cash in its second quarter on Wednesday, to $29. 2m.
AFC Energy agrees partnership with Extreme E racing series
Hydrogen power technology company AFC Energy confirmed a collaboration with Extreme E on Wednesday, to supply zero emission, hydrogen-fuelled off-grid power to the latter’s inaugural electric sports utility vehicle (SUV) racing series, beginning in early 2021.
Arcontech trades in line, expects to pay dividend
Data processing products provider Arcontech said on Wednesday that full-year profits were expected to be in line with market expectations and added that it was looking to make good on its dividend policy despite the Covid-19 pandemic.
Real Estate Investors collects 90% of rents in Q1
Midlands-focused real estate investment trust Real Estate Investors said on Wednesday that rent collection for the three months ended 30 June had risen to 90. 16%.
Alpha FX revenues grow on strong payments solutions performance
Payments group Alpha FX said on Wednesday that first-half revenues had grown on the back of two consecutive quarters of record income for its payments solutions wing.
Asos sees annual profit at top end of market expectations
Online fashion retailer Asos said on Wednesday that annual pre-tax profit was set to be towards the top end of market expectations, as it reported a 10% jump in sales for the four months to the end of June, but analysts were largely unimpressed.